Selected Grants
AVANT GUARD
Clinical TrialPrincipal Investigator · Awarded by Boston Scientific Corporation · 2024 - 2028Independent Core Lab
Clinical TrialPrincipal Investigator · Awarded by Biotronik, Inc. · 2025 - 2026COMPASS
ResearchPrincipal Investigator · Awarded by Heart Rhythm Society · 2023 - 2026ACL ADVANTAGE AF: A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation
ResearchPrincipal Investigator · Awarded by Boston Scientific Corporation · 2024 - 2026LUX-DX INSERTABLE CARDIAC MONITOR: INDEPENDENT EVENT ANALYSIS
ResearchPrincipal Investigator · Awarded by Boston Scientific Corporation · 2023 - 2025LUX PERFORM
Clinical TrialPrincipal Investigator · Awarded by Boston Scientific Corporation · 2021 - 2025Improving Outpatient Comprehensive Atrial Fibrillation Care Across Central North Carolina Through Direct Primary Care Engagement
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2024 - 2024ICD-in-HFmrEF Virtual Trial analyses
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2023 - 2024CHANGE AFib
Clinical TrialPrincipal Investigator · Awarded by American Heart Association · 2022 - 2024Safety and Effectiveness of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer
ResearchPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2019 - 2024APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION
Clinical TrialPrincipal Investigator · Awarded by Population Health Research Institute · 2019 - 2021Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2020External Relationships
- AltaThera
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic (Covidien)
- Philips Healthcare
- Zoll Medical
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.